name: Venography for congenital heart defect(s), including catheter placement, and radiological supervision and interpretation for venovenous collaterals originating from the inferior vena cava


name: Chemotherapy administration into the peritoneal cavity via implanted port


name: Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, including separate incision(s) and closure, when performed


name: Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, including separate incision(s) and closure, when performed; first 60 minutes (List separately in addition to code for primary procedure)


name: Intraoperative heated intraperitoneal chemotherapy, first 60 minutes


name: Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, first 60 minutes


name: Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, including separate incision(s) and closure, first 60 minutes


name: Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, including separate incision(s) and closure, when performed; each additional 30 minutes (List separately in addition to code for primary procedure)


name: Intraoperative heated intraperitoneal chemotherapy, each additional 30 minutes


name: Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, each additional 30 minutes


name: Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) procedure, including separate incision(s) and closure, each additional 30 minutes


name: Application of a modality to 1 or more areas; low-level laser therapy (ie, nonthermal and non-ablative) for post-operative pain reduction


name: Low-level laser therapy application for pain management after surgery


name: Caregiver Training Without the Patient Present


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community, initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs] and instrumental ADLs [iADLs], without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], and transfers, without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, and mobility, without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, and communication, without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, and swallowing, without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, and feeding, without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, and problem solving, without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices, without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], without the patient present, face to face; initial 30 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face; each additional 15 minutes (List separately in addition to code for primary service)


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community, each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs] and instrumental ADLs [iADLs], without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], and transfers, without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, and mobility, without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, and communication, without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, and swallowing, without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, and feeding, without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, and problem solving, without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices, without the patient present, face to face; each additional 15 minutes


name: Caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], without the patient present, face to face; each additional 15 minutes


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community (eg, activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, safety practices) (without the patient present), face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs] and instrumental ADLs [iADLs], without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], and transfers, without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, and mobility, without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, and communication, without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, and swallowing, without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, and feeding, without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, and problem solving, without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], instrumental ADLs [iADLs], transfers, mobility, communication, swallowing, feeding, problem solving, and safety practices, without the patient present, face to face with multiple sets of caregivers


name: Group caregiver training in strategies and techniques to facilitate the patient's functional performance in the home or community including activities of daily living [ADLs], without the patient present, face to face with multiple sets of caregivers


name: Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report


name: Noncontact near-infrared spectroscopy with image acquisition, interpretation and report, first anatomic site


name: Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), other than for screening for peripheral arterial disease, image acquisition, interpretation, and report; each additional anatomic site (List separately in addition to code for primary procedure)


name: Noncontact near-infrared spectroscopy with image acquisition, interpretation and report, each additional anatomic site


name: Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), for screening for peripheral arterial disease, including provocative maneuvers, image acquisition, interpretation, and report, one or both lower extremities


name: Noncontact near-infrared spectroscopy with provocative maneuvers, image acquisition, interpretation and report for screening for peripheral arterial disease


name: Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing


name: Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing; both components (battery and transmitter)


name: Removal of battery and transmitter of wireless cardiac stimulator for pacing of left lower chamber of heart


name: Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming


name: Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; battery component only


name: Relocation of battery of wireless cardiac stimulator for pacing of left lower chamber of heart


name: Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; transmitter component only


name: Relocation of transmitter of wireless cardiac stimulator for pacing of left lower chamber of heart


name: Removal and replacement of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming


name: Removal and replacement of pulse generator battery and transmitter of wireless heart stimulator system for pacing of lower left chamber of heart


name: Removal and replacement of pulse generator battery of wireless heart stimulator system for pacing of lower left chamber of heart


name: Implantation or replacement of posterior tibial nerve stimulating system for bladder dysfunction, accessed through skin


name: Revision or removal of posterior tibial nerve stimulating system for bladder dysfunction, accessed through skin


name: Electronic analysis with simple programming of posterior nerve stimulating system for bladder dysfunction


name: Electronic analysis with complex programming of posterior tibial nerve stimulating system for bladder dysfunction


name: Anterior lumbar or thoracolumbar vertebral body tethering


name: Tethering of 7 or fewer lower spine bones


name: Tethering of 8 or more lower spine bones


name: Revision (eg, augmentation, division of tether), replacement, or removal of thoracolumbar or lumbar vertebral body tethering, including thoracoscopy, when performed


name: Revision, replacement, or removal of lower spine tethering


name: Digitization of glass microscope slides for cytopathology, fluids, washings, or brushings, except cervical or vaginal


name: Digitization of glass microscope slides for cytopathology, fluids, washings, or brushings, except cervical or vaginal; smears with interpretation (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology of fluids, washings, or brushings, smears


name: Digitization of glass microscope slides for cytopathology, fluids, washings, or brushings, except cervical or vaginal; simple filter method with interpretation (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology of fluids, washings, or brushings, simple filter method


name: Digitization of glass microscope slides for cytopathology, concentration technique, smears, and interpretation (eg, Saccomanno technique) (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology, concentration technique


name: Digitization of glass microscope slides for cytopathology, selective-cellular enhancement technique with interpretation (eg, liquid-based slide preparation method), except cervical or vaginal (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology, selective-cellular enhancement technique


name: Digitization of glass microscope slides for cytopathology, cervical or vaginal (any reporting system), requiring interpretation by physician (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology of cervical or vaginal specimen


name: Digitization of glass microscope slides for cytopathology, smears, any other source


name: Digitization of glass microscope slides for cytopathology, smears, any other source; screening and interpretation (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology, smears requiring screening and interpretation


name: Digitization of glass microscope slides for cytopathology, smears, any other source; preparation, screening and interpretation (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology, smears requiring preparation, screening and interpretation


name: Digitization of glass microscope slides for cytopathology, smears, any other source; extended study involving over 5 slides and/or multiple stains (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology, smears requiring extended study of over 5 slides and/or multiple stains


name: Digitization of glass microscope slides for cytopathology evaluation of fine needle aspirate


name: Digitization of glass microscope slides for cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology evaluation of fine needle aspirate, first evaluation


name: Digitization of glass microscope slides for cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, each separate additional evaluation episode, same site (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for cytopathology evaluation of fine needle aspirate, each additional evaluation


name: Digitization of glass microscope slides for cytopathology, evaluation of fine needle aspirate; interpretation and report (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for consultation and report on referred slides prepared elsewhere (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for consultation and report on referred material requiring preparation of slides (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for consultation, comprehensive, with review of records and specimens, with report on referred material (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for consultation, comprehensive review


name: Digitization of glass microscope slides for pathology consultation during surgery


name: Digitization of glass microscope slides for pathology consultation during surgery; first tissue block, with frozen section(s), single specimen (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for pathology consultation during surgery, first tissue block


name: Digitization of glass microscope slides for pathology consultation during surgery; each additional tissue block with frozen section(s) (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for pathology consultation during surgery, each additional tissue block


name: Digitization of glass microscope slides for pathology consultation during surgery; cytologic examination (eg, touch preparation, squash preparation), initial site (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for pathology consultation during surgery; cytologic examination (eg, touch preparation, squash preparation), each additional site (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for immunofluorescence, per specimen


name: Digitization of glass microscope slides for immunofluorescence, per specimen; initial single antibody stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for immunofluorescence, initial single antibody stain procedure


name: Digitization of glass microscope slides for immunofluorescence, per specimen; each additional single antibody stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for immunofluorescence, each additional antibody stain procedure


name: Digitization of glass microscope slides for examination and selection of retrieved archival (ie, previously diagnosed) tissue(s) for molecular analysis (eg, KRAS mutational analysis) (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for in situ hybridization (eg, FISH), per specimen


name: Digitization of glass microscope slides for in situ hybridization (eg, FISH), per specimen; initial single probe stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for in situ hybridization, initial single probe stain procedure


name: Digitization of glass microscope slides for in situ hybridization (eg, FISH), per specimen; each additional single probe stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for in situ hybridization, each additional single probe stain procedure


name: Digitization of glass microscope slides for in situ hybridization (eg, FISH), per specimen; each multiplex probe stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for in situ hybridization, each multiplex probe stain procedure


name: Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen


name: Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen; initial single probe stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for morphometric analysis, in situ hybridization, initial manual single probe stain procedure


name: Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen; each additional single probe stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for morphometric analysis, in situ hybridization, each additional manual single probe stain procedure


name: Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen; each multiplex probe stain procedure (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for morphometric analysis, in situ hybridization, each manual multiplex probe stain procedure


name: Digitization of glass microscope slides for blood smear, peripheral, interpretation by physician with written report (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for peripheral blood smear


name: Digitization of glass microscope slides for bone marrow, smear interpretation (List separately in addition to code for primary procedure)


name: Digitization of glass microscope slides for bone marrow smear


name: Digitization of glass microscope slides for electron microscopy, diagnostic (List separately in addition to code for primary procedure)


name: Transcutaneous magnetic stimulation by focused low-frequency electromagnetic pulse, peripheral nerve, with identification and mapping of the treatment location, including noninvasive electroneurographic localization (nerve conduction localization), when performed


name: Insertion or replacement of percutaneous electrode array, spinal, with integrated neurostimulator, including imaging guidance, when performed


name: Insertion or replacement of spinal integrated nerve stimulating system with electrode array, accessed through the skin


name: Revision or removal of neurostimulator electrode array, spinal, with integrated neurostimulator


name: Revision or removal of spinal integrated nerve stimulating system with electrode array


name: Insertion or replacement of percutaneous electrode array, sacral, with integrated neurostimulator, including imaging guidance, when performed


name: Insertion or replacement of sacral integrated never stimulating system with electrode array, accessed through the skin


name: Revision or removal of neurostimulator electrode array, sacral, with integrated neurostimulator


name: Revision or removal of sacral integrated nerve stimulating system with electrode array


name: Electronic analysis with simple programming of implanted integrated neurostimulation system (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, spinal cord or sacral nerve, 1-3 parameters


name: Electronic analysis with simple programming of spinal or sacral integrated nerve stimulating system


name: Electronic analysis with complex programming of implanted integrated neurostimulation system (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, spinal cord or sacral nerve, 4 or more parameters


name: Electronic analysis with complex programming of spinal or sacral integrated nerve stimulating system


name: Motor-cognitive, semi-immersive virtual reality-facilitated gait training, each 15 minutes (List separately in addition to code for primary procedure)


name: Semi-immersive virtual reality-facilitated, motor-cognitive training for walking, each 15 minutes


name: Application of silver diamine fluoride 38%, by a physician or other qualified health care professional


name: Percutaneous transcatheter thermal ablation of nerves innervating the pulmonary arteries, including right heart catheterization, pulmonary artery angiography, and all imaging guidance


name: Pharmaco-oncologic Algorithmic Treatment Ranking


name: Patient-specific, assistive, rules-based algorithm for ranking pharmaco-oncologic treatment options based on the patient's tumor-specific cancer marker information obtained from prior molecular pathology, immunohistochemical, or other pathology results which have been previously interpreted and reported separately


name: Patient-specific, assistive, rules-based algorithm for ranking cancer drug treatment options based on the patient's tumor-specific cancer marker information obtained from previous laboratory testing which have been previously interpreted and reported separately


name: Transcatheter insertion of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed


name: Transcatheter insertion of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed; complete system (ie, right atrial and right ventricular pacemaker components)


name: Transcatheter insertion of permanent dual-chamber leadless pacemaker using fluoroscopy and device interrogation of right atrial and right ventricular pacemaker components


name: Transcatheter insertion of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed; right atrial pacemaker component (when an existing right ventricular single leadless pacemaker exists to create a dual-chamber leadless pacemaker system)


name: Transcatheter insertion of permanent dual-chamber pacemaker using fluoroscopy and device interrogation of right atrial pacemaker component


name: Transcatheter insertion of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed; right ventricular pacemaker component (when part of a dual-chamber leadless pacemaker system)


name: Transcatheter insertion of a permanent dual chamber leadless pacemaker using fluoroscopy and device interrogation of right ventricular pacemaker component


name: Transcatheter removal of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography), when performed


name: Transcatheter removal of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography), when performed; complete system (ie, right atrial and right ventricular pacemaker components)


name: Transcatheter removal of the right atrial and right ventricular components of a permanent dual-chamber leadless pacemaker using fluoroscopy


name: Transcatheter removal of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography), when performed; right atrial pacemaker component


name: Transcatheter removal of the right atrial component of a permanent dual-chamber leadless pacemaker using fluoroscopy


name: Transcatheter removal of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography), when performed; right ventricular pacemaker component (when part of a dual-chamber leadless pacemaker system)


name: Transcatheter removal of the right ventricular component of a permanent dual-chamber leadless pacemaker using fluoroscopy


name: Transcatheter removal and replacement of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed


name: Transcatheter removal and replacement of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed; dual-chamber system (ie, right atrial and right ventricular pacemaker components)


name: Transcatheter removal and replacement of permanent dual-chamber leadless pacemaker using fluoroscopy and device interrogation of right atrial and right ventricular components


name: Transcatheter removal and replacement of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed; right atrial pacemaker component


name: Transcatheter removal and replacement of permanent dual-chamber leadless pacemaker using fluoroscopy and device interrogation of right atrial component


name: Transcatheter removal and replacement of permanent dual-chamber leadless pacemaker, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography, right ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed; right ventricular pacemaker component (when part of a dual-chamber leadless pacemaker system)


name: Transcatheter removal and replacement of permanent dual-chamber leadless pacemaker using fluoroscopy and device interrogation of right ventricular component


name: Programming device evaluation (in person) with iterative adjustment of implantable device to test the function of device and to select optimal permanent programmed values, with analysis, review, and report, by a physician or other qualified health care professional, leadless pacemaker system in dual cardiac chambers


name: In-person programming device evaluation of dual-chamber leadless pacemaker with adjustment of the device to test function and to select optimal permanent values, with analysis, review and report by a physician or other qualified health care professional


name: Transcatheter superior and inferior vena cava prosthetic valve implantation (ie, caval valve implantation [CAVI])


name: Transcatheter superior and inferior vena cava prosthetic valve implantation (ie, caval valve implantation [CAVI]); percutaneous femoral vein approach


name: Implantation of a superior and inferior vena cava artificial valve using the femoral vein through the skin


name: Transcatheter superior and inferior vena cava prosthetic valve implantation (ie, caval valve implantation [CAVI]); open femoral vein approach


name: Open implantation of a superior and inferior vena cava artificial valve using the femoral vein


name: Pulmonary tissue ventilation analysis using software-based processing of data from separately captured cinefluorograph images


name: Pulmonary tissue ventilation analysis using software-based processing of data from separately captured cinefluorograph images; in combination with previously acquired computed tomography (CT) images, including data preparation and transmission, quantification of pulmonary tissue ventilation, data review, interpretation and report


name: Analysis of lung tissue ventilation using software-based processing of cinefluorography images and previously acquired CT images, including data preparation and transmission, evaluation of lung tissue ventilation data, review, interpretation, and report


name: Pulmonary tissue ventilation analysis using software-based processing of data from separately captured cinefluorograph images; in combination with computed tomography (CT) images taken for the purpose of pulmonary tissue ventilation analysis, including data preparation and transmission, quantification of pulmonary tissue ventilation, data review, interpretation and report


name: Analysis of lung tissue ventilation using software-based processing of cinefluorography images and CT images taken for the purpose of lung tissue ventilation analysis, including data preparation and transmission, evaluation of lung tissue ventilation data, review, interpretation, and report


name: Subretinal injection of a pharmacologic agent, including vitrectomy and 1 or more retinotomies


name: Subretinal injection of a drug, including vitrectomy and retinotomy


name: Remote multi-day complex uroflowmetry (eg, calibrated electronic equipment)


name: Remote multi-day complex uroflowmetry (eg, calibrated electronic equipment); set-up and patient education on use of equipment


name: Set-up and education on use of equipment for remoted electronic assessment of bladder emptying


name: Remote multi-day complex uroflowmetry (eg, calibrated electronic equipment); device supply with automated report generation, up to 10 days


name: Device supply and report generation for remote electronic assessment of bladder emptying for up to 10 days


name: Esophagogastroduodenoscopy, flexible, transoral, with volume adjustment of intragastric bariatric balloon


name: Volume adjustment of intragastric bariatric balloon using a flexible endoscope through the mouth


name: Percutaneous injection of calcium-based biodegradable osteoconductive material, proximal femur, including imaging guidance, unilateral


name: Injection through the skin of calcium-based osteoconductive material to repair upper thigh bone


name: Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine


name: Ultrasound-based radiofrequency echographic multi-spectrometry scan for measuring bone loss in hips, pelvis, or spine


name: Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (eg, array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve


name: Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (eg, array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subcutaneous


name: Insertion or replacement of integrated posterior tibial nerve stimulating system under the skin, for bladder dysfunction


name: Open insertion or replacement of integrated neurostimulation system for bladder dysfunction including electrode(s) (eg, array or leadless), and pulse generator or receiver, including analysis, programming, and imaging guidance, when performed, posterior tibial nerve; subfascial


name: Insertion or replacement of integrated posterior tibial nerve stimulating system under muscle, for bladder dysfunction


name: Revision or removal of integrated neurostimulation system for bladder dysfunction, including analysis, programming, and imaging, when performed, posterior tibial nerve


name: Revision or removal of integrated neurostimulation system for bladder dysfunction, including analysis, programming, and imaging, when performed, posterior tibial nerve; subcutaneous


name: Revision or removal of integrated posterior nerve stimulating system under skin, for bladder dysfunction


name: Revision or removal of integrated neurostimulation system for bladder dysfunction, including analysis, programming, and imaging, when performed, posterior tibial nerve; subfascial


name: Revision or removal of integrated posterior nerve stimulating system under muscle, for bladder dysfunction


name: Continuous in-person monitoring and intervention (eg, psychotherapy, crisis intervention), as needed, during psychedelic medication therapy


name: Continuous in-person monitoring and intervention (eg, psychotherapy, crisis intervention), as needed, during psychedelic medication therapy; first physician or other qualified health care professional, each hour


name: Continuous in-person monitoring and intervention (eg, psychotherapy, crisis intervention), as needed, during psychedelic medication therapy; second physician or other qualified health care professional, concurrent with first physician or other qualified health care professional, each hour (List separately in addition to code for primary procedure)


name: Continuous in-person monitoring and intervention (eg, psychotherapy, crisis intervention), as needed, during psychedelic medication therapy; clinical staff under the direction of a physician or other qualified health care professional, concurrent with first physician or other qualified health care professional, each hour (List separately in addition to code for primary procedure)


name: Continuous in-person monitoring and intervention during psychedelic medication therapy clinical staff working with the first physician or other qualified health care professional, each hour


name: Transcatheter insertion of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography) and device evaluation (eg, interrogation or programming), when performed


name: Insertion of permanent single-chamber leadless pacemaker for pacing the right upper heart chamber using imaging guidance


name: Transcatheter removal of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography), when performed


name: Removal of permanent single-chamber leadless pacemaker for pacing the right upper chamber of the heart using imaging guidance


name: Transcatheter removal and replacement of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography) and device evaluation (eg, interrogation or programming), when performed


name: Removal and replacement of single-chamber permanent leadless pacemaker for pacing the right upper chamber of the heart using imaging guidance


name: Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional, leadless pacemaker system in single-cardiac chamber


name: In-person device evaluation of single-chamber leadless pacemaker system


name: Opto-acoustic imaging, breast, unilateral, including axilla when performed, real-time with image documentation, augmentative analysis and report (List separately in addition to code for primary procedure)


name: Opto-acoustic imaging of the breast using software processing of imaging data


name: Externally applied transcranial magnetic stimulation with concomitant measurement of evoked cortical potentials with automated report


name: External application of magnetic field to stimulate nerve cells in the brain with measurement of electrical activity in the brain


name: Low-intensity extracorporeal shock wave therapy involving corpus cavernosum, low energy


name: Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion identification, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the brain during the same session


name: Quantitative MRI of the brain with comparison to previous MRI scan without MRI scan performed during the same visit


name: Quantitative magnetic resonance image (MRI) analysis of the brain with comparison to prior magnetic resonance (MR) study(ies), including lesion detection, characterization, and quantification, with brain volume(s) quantification and/or severity score, when performed, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the brain (List separately in addition to code for primary procedure)


name: Quantitative MRI of the brain with comparison to previous MRI scan with MRI scan performed during the same visit


name: Cardiovascular disease, plasma, analysis of protein biomarkers by aptamer-based microarray and algorithm reported as 4-year likelihood of coronary event in high-risk populations


name: Analysis of protein biomarkers in plasma with results reported as likelihood for a coronary event in high-risk populations


name: One month supply or less of drug or biological


name: Three month supply of drug or biological


name: CPT Codes That May Be Used for Synchronous Real-Time Interactive Audio-Video Telemedicine Services


name: Telehealth Provided Other than in Patient's Home


name: Blood specimen in inactivating molecular transport medium


name: Product of animal origin submitted as specimen


name: Pooled oral fluid specimen from sampling rope


name: Nucleic acid specimen on chemically treated filter paper


name: VTSL USDA Veterinary Services specimen type reference set


name: Target intraocular pressure of right eye


name: Surgical margin involved by primary malignant neoplasm of pharynx in excised tissue specimen


name: Surgical margin involved by noninvasive premalignant neoplasm in excised oral soft tissue specimen


name: Surgical margin closest to noninvasive premalignant neoplasm in excised pharynx specimen


name: Surgical margin closest to primary malignant neoplasm of pharynx in excised specimen


name: Anatomic location directly invaded by primary malignant neoplasm of colorectum


name: Closest surgical margin to noninvasive premalignant neoplasm in excised specimen


name: Macroscopic anatomic location of neoplasm


name: Maximum intraocular pressure of left eye


name: Maximum intraocular pressure of right eye


name: Maximum untreated intraocular pressure of left eye


name: Maximum untreated intraocular pressure of right eye


name: Histologic grade of primary malignant neoplasm of colorectum


name: Histologic type of noninvasive premalignant neoplasm


name: Automated canalith repositioning procedure chair


name: Revision of arthroplasty of head of radius


name: Replacement of temporary filling in tooth


name: Replacement of battery of neurostimulator


name: Removal of prosthesis of joint of right hip


name: Removal of prosthesis of joint of left hip


name: Presence of tumor bud in primary malignant neoplasm of colorectum


name: Presence of regression of primary malignant neoplasm of colorectum after neoadjuvant antineoplastic therapy


name: Presence of noninvasive premalignant neoplasm at tumor bed surgical margin in excised oral soft tissue specimen


name: Presence of noninvasive premalignant neoplasm at surgical margin in excised pharynx specimen


name: Presence of noninvasive premalignant neoplasm at surgical margin in excised oral soft tissue specimen


name: Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of colorectum by immunohistochemistry


name: Presence of metastatic discontinuous spread of malignant neoplasm of colorectum to pericolic tissue


name: Presence of direct invasion by primary malignant neoplasm of colorectum to nerve


name: Presence of direct invasion by primary malignant neoplasm of colorectum to lymphatic vessel and/or small blood vessel


name: Anatomic location directly invaded macroscopically by primary malignant neoplasm of urethra


name: Histologic grade of primary malignant neoplasm of salivary gland


name: Surgical margin involved by noninvasive premalignant neoplasm in excised pharynx tissue specimen


name: Ocular response analyzer tonometry - corneal compensated


name: Fitting of complete orthodontic appliance


name: Fitting of complete upper and complete lower dentures


name: Fitting of dental crown to dental implant


name: Fitting of intraoral appliance for sleep apnea


name: At increased risk for unplanned pregnancy


name: History of acquired deformity of hip following removal of prosthesis


name: History of acquired deformity of right hip following removal of prosthesis


name: Fixation of dental crown to dental implant


name: Genetic predisposition to malignant neoplasm of prostate


name: Ocular response analyzer tonometry - Goldmann-correlated


name: Histologic type of primary malignant neoplasm of colorectum


name: Insertion of complete upper and complete lower dentures


name: Laterality of primary malignant neoplasm of oral soft tissue


name: Laterality of primary malignant neoplasm of pharynx


name: Number of metastatic discontinuous tumor deposits of primary malignant neoplasm of colorectum


name: Number of tumor buds in primary malignant neoplasm of colorectum in microscopic field 0.785 square millimeter


name: Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of colorectum by immunohistochemistry


name: Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of colorectum by immunohistochemistry


name: Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of colorectum by immunohistochemistry


name: Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of colorectum by immunohistochemistry


name: Presence of direct invasion by primary malignant neoplasm of colorectum to blood vessel in pericolic tissue


name: Secondary acute angle closure due to neovascularization


name: Secondary acute angle closure due to uveitis


name: Secondary angle closure due to neovascularization


name: Secondary angle-closure due to iridocorneal endothelial syndrome


name: Family history of lysosomal storage disease


name: History of implantation of dental endosseous implant


name: Presence of direct invasion by primary malignant neoplasm of colorectum to blood vessel of colonic submucosa and/or colonic muscularis propria


name: Fitting of cleft lip or palate strapping appliance


name: Histologic grade of primary malignant neoplasm of colorectum using World Health Organization classification of tumors system fifth edition method


name: Relative location of involved inguinal lymph nodes to primary malignant neoplasm of penis


name: Relative location of involved lymph nodes to primary malignant neoplasm of pharynx


name: Relative location of involved lymph nodes to primary malignant neoplasm of oral soft tissue


name: Tumor bed surgical margin involved by primary malignant neoplasm of oral soft tissue in excised tissue specimen


name: Tumor bud score in primary malignant neoplasm of colorectum


name: Unilateral biportal endoscopic operation on spine


name: External beam radiotherapy using internal target volume approach


name: Real time neoplasm tracking external beam radiotherapy


name: Relative location of involved lymph nodes with primary malignant neoplasm of major salivary gland


name: Episcleral venous pressure above reference range


name: Transplant recipient Epstein Barr virus antibody status unknown


name: In vitro allergen specific immunoglobulin E antibody immunoassay class 0


name: In vitro allergen specific immunoglobulin E antibody immunoassay class 1


name: In vitro allergen specific immunoglobulin E antibody immunoassay class 2


name: In vitro allergen specific immunoglobulin E antibody immunoassay class 3


name: In vitro allergen specific immunoglobulin E antibody immunoassay class 4


name: In vitro allergen specific immunoglobulin E antibody immunoassay class 5


name: In vitro allergen specific immunoglobulin E antibody immunoassay class 6


name: Classes for in vitro allergen specific immunoglobulin E antibody immunoassay


name: Dexamethasone- and levofloxacin-containing product


name: Dexamethasone and levofloxacin only product


name: Gimeracil and oteracil and tegafur only product


name: Gimeracil- and oteracil- and tegafur-containing product


name: Control of Allergic Rhinitis and Asthma Test


name: Mechanism, Glasgow Coma Scale, Age, Pressure score


name: Phacomorphic secondary acute angle closure


name: Portuguese Registry of Acute Coronary Syndromes risk score


name: Pelvic disproportion due to contracted pelvis


name: Rapid Arterial Occlusion Evaluation Scale


name: Strength, Assistance walking, Rising from chair, Climbing stairs and Falls questionnaire


name: Fitting of extraoral maxillofacial prosthesis


name: Screening Tool for Risk on Nutritional Status and Growth


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Estonian Edition


name: TITANIUM DIOXIDE 0.037 g in 1 g / ZINC OXIDE 0.14 g in 1 g TOPICAL LOTION [Sunscreen-Lotion]


name: TITANIUM DIOXIDE 35 mg in 1 mL TOPICAL CREAM [Farmasi BB Cream LIGHT to MEDIUM 02]


name: TITANIUM DIOXIDE 40 mg in 1 mL TOPICAL CREAM [Farmasi CC Cream LIGHT to MEDIUM 02]


name: Titanium Dioxide 1.25 g in 5 g / Octinoxate 0.236 g in 5 g / Octocrylene 0.225 g in 5 g / Octisalate 0.135 g in 5 g / Avobenzone 0.075 g in 5 g / Oxybenzone 0.075 g in 5 g TOPICAL POWDER [Brush and Go All Skin types Matte Finish Tone 1]


name: ZINC OXIDE 12 g in 100 mL CUTANEOUS LIQUID


name: ZINC OXIDE 200 mg in 1 mL TOPICAL LOTION [Think Aloe and Tea Leaves Zinc oxide]


name: ADENOSINE 0.04 g in 100 mL / NIACINAMIDE 2 g in 100 mL TOPICAL CREAM [Reoganic Body Firming StretchCream]


name: OXANTEL PAMOATE 1 g in 1 g NOT APPLICABLE POWDER


name: {14 (valbenazine 40 MG Oral Capsule) / 14 (valbenazine 60 MG Oral Capsule) } Pack


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 9 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL LOTION [Mary Kay TimeWise Daytime Defender Sunscreen Broad Spectrum SPF 30]


name: CALCIUM LEVULINATE 1 g in 1 g NOT APPLICABLE POWDER


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 110 mg in 1 mL TOPICAL CREAM [DERMAKA Broad Spectrum SPF-42 Sunscreen Untinted]


name: ZINC OXIDE 210 mg in 1 g TOPICAL STICK [Kids Face and Body Sunscreen SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Aveeno Baby Continuous Protection Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 2 g in 100 g / OCTISALATE 2 g in 100 g / HOMOSALATE 3.5 g in 100 g / OCTOCRYLENE 4 g in 100 g TOPICAL LOTION [HAWAIIAN TROPIC]


name: AVOBENZONE 2.7 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 5.2 g in 100 g TOPICAL LOTION [HAWAIIAN TROPIC]


name: ALUMINUM CHLOROHYDRATE 0.15 g in 1 g TOPICAL CLOTH [CERTAIN DRI]


name: HOMOSALATE 3060 mg in 45 mL / OCTOCRYLENE 4500 mg in 45 mL / OCTISALATE 2250 mg in 45 mL / AVOBENZONE 1350 mg in 45 mL TOPICAL CREAM [ZO Skin Health Daily Sheer Broad-Spectrum Sunscreen SPF 50 Water Resistant (40 Minutes)]


name: HOMOSALATE 7 g in 100 g / AVOBENZONE 2.2 g in 100 g / OCTOCRYLENE 4.2 g in 100 g TOPICAL LOTION [HAWAIIAN TROPIC]


name: HOMOSALATE 7 g in 100 mL / OCTOCRYLENE 5 g in 100 mL / AVOBENZONE 2 g in 100 mL TOPICAL CREAM [SPF 30 Moisturizer with Aloe Vera]


name: HOMOSALATE 8 g in 100 g / OCTOCRYLENE 6 g in 100 g / AVOBENZONE 2.7 g in 100 g TOPICAL SPRAY [HAWAIIAN TROPIC]


name: HOMOSALATE 9 g in 100 g / AVOBENZONE 2.7 g in 100 g / OCTOCRYLENE 5 g in 100 g / OCTISALATE 4 g in 100 g TOPICAL LOTION [HAWAIIAN TROPIC]


name: HOMOSALATE 9 mg in 100 mg / ZINC OXIDE 7.8 mg in 100 mg / OCTISALATE 4.5 mg in 100 mg TOPICAL CREAM [Buildable Blur]


name: OCTOCRYLENE 6 mg in 100 mg / OCTISALATE 3.2 mg in 100 mg TOPICAL CREAM [Leg Body Makeup]


name: ZINC OXIDE 0.2 g in 1 g TOPICAL CREAM [78 x 36 SPF 30 Active]


name: ZINC OXIDE 23.8 g in 100 g TOPICAL STICK [BANANA BOAT]


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Turqoz 28 Day]


name: AVOBENZONE 29.5 mg in 1 mL / OCTINOXATE 73.5 mg in 1 mL / HOMOSALATE 97.9 mg in 1 mL / OCTOCRYLENE 61.5 mg in 1 mL TOPICAL CREAM [Dr.C.Tuna Sun Body SPF50]


name: AVOBENZONE 29.5 mg in 1 mL / OCTINOXATE 74.5 mg in 1 mL / HOMOSALATE 99.5 mg in 1 mL / OCTOCRYLENE 61.9 mg in 1 mL TOPICAL CREAM [Dr.C.Tuna Sun Face Cream SPF50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 120 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: OCTOCRYLENE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION [Expedition BackCountry SPF 50]


name: sterile water diluent intrathecal solution


name: Ensure Plus With Fiber Nutrition Shake (Vanilla)


name: FDS Intimate Deodorant Spray Extra Strength


name: Thermacare Back Pain Therapy Heatwraps L/XL


name: Xymogen FIT Food Lean Collagen Mocha Latte


name: Suspension, Multi Ingredient Topical application Suspension


name: Titanium Dioxide/Zinc Oxide 6%-4.7% Topical application Stick


name: Titanium Dioxide/Zinc Oxide 3%-10% Topical application Lotion


name: Titanium Dioxide/Zinc Oxide 9%-7% Topical application Lotion


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2.8%-9.5%-4.8%-7% Topical application Lotion


name: Titanium Dioxide/Zinc Oxide 10.1%-7.8% Topical application Lotion


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-12.5%-5%-8% Topical application Cream


name: Avobenzone/Octisalate/Octocrylene 3%-5%-7% Topical application Lotion


name: OCTOCRYLENE 5 g in 100 g / OCTISALATE 3 g in 100 g / AVOBENZONE 2.5 g in 100 g TOPICAL LIPSTICK [Expedition BackCountry SPF 30]


name: DRESSING,GEL FIBER SILVER 4IN X 4.75IN MC#177400


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2668-F


name: VAD DRIVELINE MAINTENANCE KIT MEDLINE #EBSI1493


name: VAD DRIVELINE MAINTENANCE KIT MEDLINE #EBSI1494


name: BANDAGE,STRETCH,CONFORMING 2IN X 75IN STERILE


name: DRESSING,AQUACEL AG ADVANTAGE SURGICAL 3.5IN X 14IN C#422607


name: CATHERIZATION SET,INTERMITTENT 16FR RUSCH #EC160


name: CATHETER,SELF-CATH SOFT 14FR COLOPLAST #4114


name: SUCTION TUBE ATTACHMENT DEVICE NEOTECH #N204


name: TAPE,ELASTIC CLOTH,2IN X 10IN KINESIO,BLACK


name: CATHETER,FOLEY SILICONE 2-WAY 26FR 5ML TELEFLEX #170605260


name: CONNECTOR,FLEXIBLE 15MM X 15MM CAREFUSION #3215


name: Modia Opioid Use Disorder Support Software


name: POLIGRIP Denture Adhesive Cream (Original)


name: SilvaSorb Silver Antimicrobial Wound Gel


name: Vorvida Problematic Alcohol Use Support Software


name: AspyreRx Digital Behavioral Therapeutic Device


name: CVS Vitamin E 27,000mg Moisturizing Topical Oil


name: Ensure Original with Fiber Nutrition Shake (Vanilla)


name: FORA 6 Connect Multi-functional Monitoring System


name: Sodium Chloride 0.9% Solution for injection [Saline Flush]


name: emollient combination no.119 TOPICAL CREAM (GRAM)


name: pediatric nutrit,milk based,iron/docosahex.acid/arachid.acid 13.9 gram-508 kcal/100 gram ORAL POWDER (GRAM)


name: silicone,dressing/foam bandage 10" X 9" TOPICAL BANDAGE


name: silicone,dressing/foam bandage 7" X 7" TOPICAL BANDAGE


name: silicone,dressing/foam bandage 9" X 9" TOPICAL BANDAGE


name: whey protein isolate/collagen, hydrolysate (bovine) 16 gram-90 kcal/60 mL ORAL LIQUID (ML)


name: COVID-19,influenza A and B molecular nucleic acid test assay MISCELL KIT


name: TITANIUM DIOXIDE 80 mg in 1 g / ZINC OXIDE 38 mg in 1 g TOPICAL CREAM [Clove Hill Tinted Mineral Sunscreen SPF 40]


name: MENTHOL 0.05 g in 4.66 g / VITAMIN A 0.01 g in 4.66 g TOPICAL CLOTH [Skineez]


name: OCTOCRYLENE 10 g in 100 g / HOMOSALATE 10 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Eucerin Face immersive Hydration]


name: STARCH, CORN 31.75 g in 100 g TOPICAL PATCH [Slimming Patch]


name: ZINC OXIDE 19 g in 100 g TOPICAL CREAM [Wonderscreen Broad Spectrum SPF 30 Shade 1]


name: rinse media solution for donislecel-jujn


name: COVID-19, flu A and B molecular nucleic test assay


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine Toms of Maine Cucumber Aloe AP wo Olea]


name: ZINC OXIDE 19 g in 100 g TOPICAL CREAM [Wonderscreen Tinted Broad Spectrum SPF 30 Shade 3]


name: ZINC OXIDE 182 mg in 1 mL TOPICAL CREAM [Skin Laundry Sun Defense Mineral SPF 30 Sunscreen Broad Spectrum SPF 30 UVA UVB]


name: ZINC OXIDE 18 g in 100 mL TOPICAL SOLUTION [KARI GRAN ESSENTIAL SPF SPF 30]


name: AVOBENZONE 0.13 g in 4.25 g / OCTINOXATE 0.28 g in 4.25 g / OCTOCRYLENE 0.06 g in 4.25 g / OCTISALATE 0.21 g in 4.25 g TOPICAL STICK


name: BEMOTRIZINOL 5 mg in 1 mL / ETHYLHEXYL TRIAZONE 27 mg in 1 mL / ECAMSULE 26.4 mg in 1 mL / POLYSILICONE-15 10 mg in 1 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 10 mg in 1 mL TOPICAL CREAM [P.CALM Water Barrier Suncream]


name: STARCH, CORN 31.75 g in 100 g TOPICAL PATCH [Rotosxika SLIMMING patch]


name: STARCH, CORN 31.75 g in 100 g TOPICAL PATCH [Xinhuazhx SLIMMING patch]


name: Capsaicin;Diclofenac Sodium 0.025%; 2% Multiple Routes Kit [Diclareal]


name: OCTOCRYLENE 8 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL CUTANEOUS SPRAY


name: TITANIUM DIOXIDE 90 mg in 1 mL / OCTOCRYLENE 48 mg in 1 mL / AVOBENZONE 14.4 mg in 1 mL TOPICAL CREAM [Multi-Vit Sun Protector SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Mela B3 UV Daily Sunscreen Broad Spectrum SPF 30]


name: ZINC OXIDE 59 mg in 1 mL / TITANIUM DIOXIDE 24 mg in 1 mL TOPICAL EMULSION [CL EB MATTE MAKEUP BROAD SPECTRUM SPF 15]


name: Fenbendazole 1 kg in 1 kg NOT APPLICABLE POWDER


name: OCTOCRYLENE 8.5 g in 100 g / AVOBENZONE 2.8 g in 100 g / OCTISALATE 4.7 g in 100 g / HOMOSALATE 9.5 g in 100 g TOPICAL LOTION [HAWAIIAN TROPIC SUNSCREEN SHEER TOUCH SPF 70]


name: ZINC OXIDE 197 mg in 1 g TOPICAL STICK [Babo Botanicals Sensitive Baby Mineral Sunscreen SPF50]


name: adapalene / benzoyl peroxide / clindamycin


name: CDISC Questionnaire Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Test Name Terminology


name: CDISC Questionnaire Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Test Code Terminology


name: CDISC Questionnaire Observer Global Impression Generic Modification Version Test Name Terminology


name: CDISC Questionnaire Observer Global Impression Generic Modification Version Test Code Terminology


name: CDISC Brief Questionnaire of Smoking Urges Test Name Terminology


name: CDISC Brief Questionnaire of Smoking Urges Test Code Terminology


name: CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris Test Name Terminology


name: CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris Test Code Terminology


name: CDISC Clinical Classification Comfort Behavior Scale Test Name Terminology


name: CDISC Clinical Classification Comfort Behavior Scale Test Code Terminology


name: CDISC Clinical Classification Cigarette Evaluation Questionnaire Extended-Screening Test Name Terminology


name: CDISC Clinical Classification Cigarette Evaluation Questionnaire Extended-Screening Test Code Terminology


name: CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Response Terminology


name: CDISC Clinical Classification Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Standardized Character Response Terminology


name: CDISC SEND Genetic Toxicology In vivo Method Terminology


name: CDISC SEND Genetic Toxicology In vivo Category Terminology


name: CDISC SEND Genetic Toxicology In vivo Subcategory Terminology


name: CDISC SEND Genetic Toxicology In vivo Test Name Terminology


name: CDISC Protocol Pharmacology Attribute Terminology


name: CDISC Questionnaire FACIT-Searchable Item Library Pediatric Version Test Name Terminology


name: CDISC Questionnaire FACIT-Searchable Item Library Pediatric Version Test Code Terminology


name: CDISC DDF Biomedical Concept Attribute Terminology


name: CDISC DDF Biomedical Concept Category Attribute Terminology


name: CDISC DDF Biomedical Concept Property Attribute Terminology


name: CDISC DDF Biomedical Concept Surrogate Attribute Terminology


name: CDISC DDF Response Code Attribute Terminology


name: CDISC DDF Schedule Timeline Attribute Terminology


name: CDISC DDF Scheduled Decision Instance Attribute Terminology


name: CDISC DDF Scheduled Instance Attribute Terminology


name: DDF Timing Relative To From Attribute Terminology


name: CDISC DDF Timing Type Value Set Terminology


name: CDISC DDF Timing Relative To From Value Set Terminology


name: CDISC Protocol Biomarker Attribute Terminology


name: CDISC Protocol Biomarker Category Value Set Terminology


name: CDISC SEND Genetic Toxicology In vivo Test Code Terminology


name: Lenalidomide Prolonged-release Formulation NEX-20A


name: Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes


name: Analysis of Information Provided by User/Third Party


name: Cause Traced to Non-Device Related Factors


name: Packaging Contains Incorrect or Incomplete Device


name: Beehive Dispersion in Sachet Dosage Form


name: Cutaneous Solution in Single-dose Container Dosage Form


name: Dispersible Tablet for Dose Dispenser Dosage Form


name: Ear Drops, Suspension in Single-dose Container Dosage Form


name: Effervescent Granules for Oral Suspension Dosage Form


name: Emulsion for Infusion in Administration System Dosage Form


name: Emulsion for Injection/Infusion in Pre-filled Syringe Dosage Form


name: Eye Drops, Emulsion in Single-dose Container Dosage Form


name: Eye Drops, Prolonged-Release Solution in Single-dose Container Dosage Form


name: Eye Drops, Solution in Single-dose Container Dosage Form


name: Eye Drops, Suspension in Single-dose Container Dosage Form


name: Eye Gel in Single-dose Container Dosage Form


name: Eye Ointment in Single-dose Container Dosage Form


name: Film-Coated Tablet and Gastro-Resistant Granules in Sachet Dosage Form


name: Gastro-Resistant Granules for Oral Suspension in Sachet Dosage Form


name: Gel in Pressurized Container Dosage Form


name: Granules for Oral Suspension in Sachet Dosage Form


name: Granules in Single-dose Container Dosage Form


name: Implant in Pre-filled Syringe Dosage Form


name: Effervescent Tablet Inhalation Vapor Dosage Form


name: Intravitreal Implant in Applicator Dosage Form


name: Modified-release Hard Capsule Dosage Form


name: Modified-release Soft Capsule Dosage Form


name: Modified-release Granule for Oral Suspension Dosage Form


name: Nasal Drops, Solution in Single-dose Container Dosage Form


name: Nasal Spray, Solution in Single-dose Container Dosage Form


name: Oral Solution in Single-dose Container Dosage Form


name: Oral Solution/Concentrate for Nebulizer Solution Dosage Form


name: Oral Suspension in Pre-filled Oral Applicator Dosage Form


name: Pillules in Single-dose Container Dosage Form


name: Powder and Solvent for Prolonged-Release Suspension for Injection in Pre-filled Pen Dosage Form


name: Powder and Solvent for Prolonged-Release Suspension for Injection in Pre-filled Syringe Dosage Form


name: Powder and Solvent for Solution for Injection in Cartridge Dosage Form


name: Powder and Solvent for Solution for Injection in Pre-filled Pen Dosage Form


name: Powder and Solvent for Solution for Injection in Pre-filled Syringe Dosage Form


name: Powder and Solvent for Suspension for Injection in Pre-filled Syringe Dosage Form


name: Powder for Oral Solution in Sachet Dosage Form


name: Powder for Oral/Rectal Suspension in Sachet Dosage Form


name: Extended Release Granule for Oral Suspension Dosage Form


name: Prolonged-Release Granules in Sachet Dosage Form


name: Prolonged-Release Suspension for Injection in Pre-filled Syringe Dosage Form


name: Solution and Suspension for Suspension for Injection in Pre-filled Syringe Dosage Form


name: Solution for Blood Fraction Modification Dosage Form


name: Solution for Infusion in Administration System Dosage Form


name: Solution for Infusion in Pre-filled Syringe Dosage Form


name: Solution for Injection in Administration System Dosage Form


name: Solution for Injection in Cartridge Dosage Form


name: Solution for Injection in Dose-Dispenser Cartridge Dosage Form


name: Solution for Injection in Needle-Free Injector Dosage Form


name: Solution for Injection in Pre-filled Injector Dosage Form


name: Solution for Injection in Pre-filled Pen Dosage Form


name: Solution for Injection in Pre-filled Syringe Dosage Form


name: Solution for Injection/Infusion in Pre-filled Syringe Dosage Form


name: Suspension for Injection in Cartridge Dosage Form


name: Suspension for Injection in Pre-filled Injector Dosage Form


name: Suspension for Injection in Pre-filled Pen Dosage Form


name: Suspension for Injection in Pre-filled Syringe Dosage Form


name: Ear Drops, Solution in Single-dose Container Dosage Form


name: Powder and Solvent for Suspension for Injection in Multidose Container Dosage Form


name: Solution for Injection in Multidose Container Dosage Form


name: Suspension for Injection in Multidose Container Dosage Form


name: Scavenger Receptor Cysteine-Rich Type 1 Protein M130 Measurement


name: Prolonged-Release Suspension for Injection in Pre-filled Pen Dosage Form


name: Lyophilisate for Emulsion for Injection Dosage Form


name: Effervescent Powder and Powder for Oral Suspension Dosage Form


name: Solution for Infusion in Cartridge Dosage Form


name: Powder and Solution for Suspension for Injection Dosage Form


name: Nasal Powder in Single-Dose Container Dosage Form


name: Modified-release Oral Suspension Dosage Form


name: Gastro-resistant Powder for Oral Suspension Dosage Form


name: Gastro-Resistant Powder and Solvent for Oral Suspension Dosage Form


name: Concentrate for Dispersion for Injection Dosage Form


name: Cause Linked to Device but Unable to Trace More Specifically


name: Concentrate and Solvent for Intravesical Solution Dosage Form


name: Concentrate and Solvent for Dispersion for Injection Dosage Form


name: Effervescent Powder and Suspension for Oral Suspension Dosage Form


name: Powder for Oral Suspension in Sachet Dosage Form


name: Oral Solution in Multidose Container with Metering Pump Dosage Form


name: Film-Coated Granules in Single-Dose Container Dosage Form


name: Concentrate and Solvent for Oral Solution Dosage Form


name: Central Memory Cytotoxic T-Lymphocyte Sub-Population to Cytotoxic T-Lymphocyte Ratio Measurement


name: Dispersion for Injection in Pre-filled Syringe Dosage Form


name: Granules for Use in Drinking Water/Milk Dosage Form


name: Eye Drops, Solution plus Eye Ointment Dosage Form


name: mCode Elixhauser Alcohol Abuse Value Set


name: mCode Elixhauser Blood Loss Anemia Value Set


name: mCode Elixhauser Metastatic Cancer Value Set


name: mCode Elixhauser Malignant Solid Tumors in Situ Value Set


name: mCode Elixhauser Malignant Solid Tumors without Metastases Value Set


name: mCode Elixhauser Chronic Pulmonary Disease Value Set


name: mCode Elixhauser Coagulation Deficiency Value Set


name: mCode Elixhauser Congestive Heart Failure Value Set


name: mCode Elixhauser Deficiency Anemia Value Set


name: mCode Elixhauser Diabetes with Chronic Complications Value Set


name: mCode Elixhauser Diabetes without Chronic Complications Value Set


name: mCode Elixhauser Hypertension, Complicated Value Set


name: mCode Elixhauser Hypertension, Uncomplicated Value Set


name: mCode Elixhauser Hypothyroidism Value Set


name: mCode Elixhauser Mild Liver Disease Value Set


name: mCode Elixhauser Moderate to Severe Liver Disease Value Set


name: mCode Elixhauser Neurological Movement Disorder Value Set


name: mCode Elixhauser Neurological Seizure Disorder Value Set


name: mCode Elixhauser Other Neurological Disorder Value Set


name: mCode Elixhauser Other Thyroid Disorder Value Set


name: mCode Elixhauser Peripheral Vascular Disease Value Set


name: mCode Elixhauser Pulmonary Circulation Disorder Value Set


name: mCode Elixhauser Moderate Renal Failure Value Set


name: mCode Elixhauser Severe Renal Failure Value Set


name: mCode Elixhauser Rheumatoid Arthritis and Collagen Vascular Disease Value Set


name: mCode Elixhauser Chronic Peptic Ulcer Disease Value Set


name: mCode Elixhauser Valvular Disease Value Set


name: mCode Staging Type Value Set (for Distant Metastases Category)


name: mCode Staging Type for Primary Tumor Category Value Set


name: mCode Staging Type for Regional Node Category Value Set


name: mCode Staging Type for Stage Group Value Set


name: mCode Radiotherapy Treatment Location Qualifier Value Set


name: mCode Radiotherapy Treatment Location Value Set


name: mCode Radiotherapy Volume Type Value Set


name: mCode Treatment Termination Reason Value Set


name: FLT3 NP_004110.2:p.D835X Variants [Presence] in Blood or Tissue by Molecular Genetics Method


name: Have not Figured Out or Is Figuring Out Sexuality


name: Blindness or Have Difficulty Seeing Question


name: Have Difficulty Concentrating, Remembering, and Deciding Question


name: Have Difficulty Walking or Climbing Stairs Question


name: Have Difficulty Dressing or Bathing Question


name: Have Difficulty Doing Errands Alone Question


name: Endoscopic Ultrasound-Guided Radiofrequency Ablation


name: RAS Signal Transduction Pathway Activated


name: Ipilimumab/Nivolumab Followed by Nivolumab Regimen


name: Additional or Unexpected Endoscopic Procedure


name: Administrative and Specialized Secretary


name: Architect, Planner, Surveyor and Designer


name: Artistic, Cultural and Culinary Associate Professional


name: Blacksmith, Toolmaker and Related Trades Worker


name: Building Finisher and Related Trades Worker


name: Building Frame and Related Trades Worker


name: Business Services and Administration Manager


name: Chemical and Photographic Products Plant and Machine Operator


name: Domestic, Hotel and Office Cleaner and Helper


name: Electronics and Telecommunications Installer and Repairer


name: Financial and Mathematical Associate Professional


name: Food and Related Products Machine Operator


name: Food Processing and Related Trades Worker


name: Government Regulatory Associate Professional


name: Hairdresser, Beautician and Related Worker


name: Information and Communications Technology Operations and User Support Technician


name: Information and Communications Technology Service Manager


name: Life Science Technician and Related Associate Professional


name: Locomotive Engine Driver and Related Worker


name: Manufacturing, Mining, Construction and Distribution Manager


name: Metal Processing and Finishing Plant Operator


name: Mining and Mineral Processing Plant Operator


name: Mining, Manufacturing and Construction Supervisor


name: Nursing and Midwifery Associate Professional


name: Other Stationary Plant and Machine Operator


name: Painter, Building Structure Cleaner and Related Trades Worker


name: Physical and Engineering Science Technician


name: Primary School and Early Childhood Teacher


name: Production Manager in Agriculture, Forestry and Fishery


name: Rubber, Plastic and Paper Products Machine Operator


name: Sales, Marketing and Development Manager


name: Sales, Marketing and Public Relations Professional


name: Sheet and Structural Metal Worker, Molder and Welder, and Related Worker


name: Ship and Aircraft Controller and Technician


name: Software and Applications Developer and Analyst


name: Subsistence Fisherman, Hunter, Trapper and Gatherer


name: Subsistence Mixed Crop and Livestock Farmer


name: Textile, Fur and Leather Products Machine Operator


name: Traditional and Complementary Medicine Associate Professional


name: Traditional and Complementary Medicine Professional


name: Vehicle, Window, Laundry and Other Hand Cleaning Worker


name: Wood Processing and Papermaking Plant Operator


name: Wood Treater, Cabinet-maker and Related Trades Worker


name: Legal, Social and Religious Associate Professional


name: Modified Chang Staging System for Medulloblastoma


name: Modified Macdonald Tumor Response Criteria


name: International Neuroblastoma Response Criteria, Park 2017


name: International Neuroblastoma Response Criteria, Brodeur 1993


name: Feel Upset About Genetic Test Result Question


name: Feel Sad About Genetic Test Result Question


name: Feel Anxious or Nervous About Genetic Test Result Question


name: Feel Guilty About Genetic Test Result Question


name: Feel Relieved About Genetic Test Result Question


name: Feel Happy About Genetic Test Result Question


name: Worried About Risk of Getting Cancer or Cancer Recurrence Question


name: Feel Frustrated that There are No Definite Cancer Prevention Guidelines for Me Question


name: Feel Concerned About how Genetic Test Results will Affect Insurance Status Question


name: Feel that Family has Been Supportive During Genetic Counseling and Testing Process Question


name: Feel Regret About Getting Genetic Test Results Question


name: Feel Guilty About Possibly Passing on Disease Risk to Children Question


name: Feel that Genetic Test Result has Made it Harder to Cope with Cancer Question


name: Feel that Genetic Test Result has Made it Easier to Cope with Cancer Question


name: Worry that Genetic Counseling and Testing has Created Conflict within Family Question


name: Worry About Possibility of Children Getting Cancer Question


name: Have Problems Enjoying Life Because of Genetic Test Result Question


name: Have Difficulty Making Decisions About Cancer Screening or Prevention Question


name: Have Difficulty Talking About Genetic Test Results with Family Members Question


name: Satisfied with Family Communication About Genetic Test Result Question


name: Uncertain About What Genetic Test Result Means About Cancer Risk Question


name: Uncertain About What Genetic Test Result Means for Cancer Risk of Children and/or Family Question


name: Clearly Understand Choices for Cancer Prevention or Early Detection Question


name: Thinking About my Genetic Test Results has Affected my Work or Family Life Question


name: Babesia microti IgG Antibody Measurement


name: Professional Healthcare Organization or Group


name: Lesion with Diameter at Least 1 mm and at Most 10 mm


name: Lesion with Diameter at Least 11 mm and at Most 20 mm


name: Clinical and Biochemical Assessments Indicator


name: Tumor Infiltrating Lymphocyte Count per High Power Field


name: De Novo Onset of Chronic Graft Versus Host Disease


name: Progressive Onset of Chronic Graft Versus Host Disease


name: Quiescent Onset of Chronic Graft Versus Host Disease


name: End of Consolidation Therapy Occurrence Indicator


name: End of Treatment Course Occurrence Indicator


name: End of Treatment Course 1 Occurrence Indicator


name: End of Treatment Course 2 Occurrence Indicator


name: First Complete Response Occurrence Indicator


name: Presence of Clear Cytoplasm Less than or Equal to 25 Percent


name: Monoclonal B-Lymphocytes More Than 5 x 10^9/L in Peripheral Blood


name: Monoclonal B-Lymphocytes Less Than 5 x 10^9/L in Peripheral Blood


name: Bone Marrow Clonal B-Cell Lymphocytic Infiltrate


name: Iodine/Thuja occidentalis/Echinancea-based Homeopathic Formulation


name: Immunoglobulin M-Positive Neoplastic Cells Present


name: Immunoglobulin Heavy Chain Class Switch Positive Neoplastic Cells


name: Immunoglobulin Heavy Chain Class Switch Associated with Immunoglobulin G Expression in Neoplastic Cells


name: Immunoglobulin Heavy Chain Class Switch Associated with Immunoglobulin G4 Expression in Neoplastic Cells


name: Testosterone Level Greater than 50 ng/dL Below Normal Range


name: Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Questionnaire Question


name: Observer Global Impression Generic Modification Version Questionnaire Question


name: Brief Questionnaire of Smoking Urges Questionnaire Question


name: Canadian Cardiovascular Society Grading of Angina Pectoris Clinical Classification Question


name: Comfort Behavior Scale Clinical Classification Question


name: Cigarette Evaluation Questionnaire Extended-Screening Clinical Classification Question


name: Canadian Cardiovascular Society Grading of Angina Pectoris TCCSGA101 Question Clinical Classification Original Response


name: Canadian Cardiovascular Society Grading of Angina Pectoris TCCSGA101 Question Clinical Classification Standardized Character Response


name: North Star Ambulatory Assessment 2017 Clinical Classification


name: Functional Assessment of Chronic Illness Therapy-Item GP5 Version 4 Questionnaire


name: Observer Global Impression Generic Modification Version Questionnaire


name: Canadian Cardiovascular Society Grading of Angina Pectoris Clinical Classification


name: Comfort Behavior Scale Clinical Classification


name: Cigarette Evaluation Questionnaire Extended-Screening Clinical Classification


name: FACIT-Item GP5 Version 4 - Bothered by Treatment Side Effect


name: OGI Generic Modification Version - Severity


name: OGI Generic Modification Version - Change


name: OGI Generic Modification Version - Improvement


name: Brief Questionnaire of Smoking Urges - Desire Cigarette Right Now


name: Brief Questionnaire of Smoking Urges - Nothing Better Than Cigarette Now


name: Brief Questionnaire of Smoking Urges - Probably Would Smoke Now


name: Brief Questionnaire of Smoking Urges - Control Things Better Could Smoke


name: Brief Questionnaire of Smoking Urges - All I Want Right Now Is Cigarette


name: Brief Questionnaire of Smoking Urges - Have an Urge for a Cigarette


name: Brief Questionnaire of Smoking Urges - A Cigarette Would Taste Good Now


name: Brief Questionnaire of Smoking Urges - Do Anything for a Cigarette Now


name: Brief Questionnaire of Smoking Urges - Smoking Make Me Less Depressed


name: Brief Questionnaire of Smoking Urges - Going Smoke as Soon as Possible


name: Brief Questionnaire of Smoking Urges - Factor 1 Scale


name: Brief Questionnaire of Smoking Urges - Factor 2 Scale


name: Brief Questionnaire of Smoking Urges - General Factor Scale


name: Comfort-B - Details Sedatives/Analgesics


name: CESE-Screening - Did It Help You Concentrate


name: CESE-Screening - Did It Make You Feel More Awake


name: CESE-Screening - Did It Reduce Your Hunger


name: CESE-Screening - Did It Make You Nauseated


name: CESE-Screening - Did It Make You Less Irritable


name: CESE-Screening - Did You Enjoy Sensations Throat


name: CESE-Screening - Did It Immediately Reduce Craving


name: Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade I


name: Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade II


name: Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade III


name: Canadian Cardiovascular Society Grading of Angina Pectoris CCSGA101 Original Result - Grade IV


name: Measurable Residual Disease 0.1 Percent or Greater


name: Activating RAF Family Gene Fusion Positive


name: Bictegravir Sodium/Emtricitabine/Tenofovir Alafenamide Fumarate


name: Cluster of Differentiation Expression Measurement


name: High intensity focused ultrasound ablation of prostate


name: Mast/Stem Cell Growth Factor Receptor Kit Measurement


name: Heart Rate Variability, Standard Deviation NN Interval Measurement


name: SEND Implementation Guide-Genetic Toxicology


name: Half Maximal Effective Agent Concentration


name: Progenitor B-Lymphocyte to Total Cells Ratio Measurement


name: Granulocytes Subpopulation to Granulocytes Ratio Measurement


name: Intermediate Monocytes to Lymphocyte Subpopulation Ratio Measurement


name: Gut-Homing Cytotoxic Memory T-Lymphocyte Count


name: Gut-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Memory T-Lymphocyte Count


name: Skin-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Memory T-Lymphocyte to Cytotoxic Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation Count


name: Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Cytotoxic Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Central Memory T-Lymphocyte Count


name: Gut-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Central Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Central Memory T-Lymphocyte Count


name: Skin-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Central Memory T-Lymphocyte to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation Count


name: Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Cytotoxic Central Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Central Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Central Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Count


name: Gut-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic Effector T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Count


name: Skin-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Effector Memory T-Lymphocyte to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation Count


name: Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Effector Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Count


name: Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Count


name: Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation Count


name: Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Cytotoxic Terminal Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Memory T-Lymphocyte Count


name: Gut-Homing Helper Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Memory T-Lymphocyte to Helper Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Memory T-Lymphocyte Count


name: Skin-Homing Helper Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Memory T-Lymphocyte to Helper Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Memory T-Lymphocyte Subpopulation


name: Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Helper Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Central Memory T-Lymphocyte Count


name: Gut-Homing Helper Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Central Memory T-Lymphocyte to Helper Central Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper Central Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Central Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Central Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Central Memory T-Lymphocyte Count


name: Skin-Homing Helper Central Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Central Memory T-Lymphocyte to Helper Central Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation Count


name: Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Helper Central Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Central Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Central Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Effector Memory T-Lymphocyte Count


name: Gut-Homing Helper Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Effector Memory T-Lymphocyte to Helper Effector Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper Effector Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Effector Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Effector Memory T-Lymphocyte Count


name: Skin-Homing Helper Effector Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Effector Memory T-Lymphocyte to Helper Effector Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation Count


name: Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Helper Effector Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Effector Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Effector Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Terminal Memory T-Lymphocyte Count


name: Gut-Homing Helper Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Terminal Memory T-Lymphocyte to Helper Terminal Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Count


name: Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper Terminal Memory T-Lymphocyte Ratio Measurement


name: Gut-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Gut-Homing Helper Terminal Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Terminal Memory T-Lymphocyte Count


name: Skin-Homing Helper Terminal Memory T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Terminal Memory T-Lymphocyte to Helper Terminal Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation Count


name: Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Helper Terminal Memory T-Lymphocyte Ratio Measurement


name: Skin-Homing Helper Terminal Memory T-Lymphocyte Subpopulation to Skin-Homing Helper Terminal Memory T-Lymphocyte Ratio Measurement


name: Granulocyte to Non-TBNK Leukocyte Ratio Measurement


name: Cytoplasmic CD223 Expression Measurement


name: Plasma Membrane CD223 Expression Measurement


name: Disease Indication Under Study Contributed to Death Indicator


name: Heparin Binding EGF Like Growth Factor Measurement


name: Platelet Derived Growth Factor Isoform BB Measurement


name: Chemokine (C-C Motif) Ligand 1 Measurement


name: Neurofilament Heavy Polypeptide Measurement


name: Serine Peptidase Inhibitor Kazal Type 1 Measurement


name: Tissue Inhibitor of Metalloproteinase 2 Measurement


name: Transferrin Receptor Protein 1 Measurement


name: Angiopoietin-Related Protein 4 Measurement


name: Growth Differentiation Factor 2 Measurement


name: Chemokine (C-C Motif) Ligand 15 Measurement


name: Soluble TNF Receptor Superfamily Mem 7 Measurement


name: Complement Factor H-Related Protein 1 Measurement


name: Fatty Acid Binding Protein 4 Measurement


name: Amyloid Beta 1-42 to Amyloid Beta 1-40 Ratio Measurement


name: Escherichia coli K1 and/or Neisseria meningitidis Group B Antigen Measurement


name: Multi-Target High Risk Human Papillomavirus Types DNA Measurement


name: Multi-Target High Risk Human Papillomavirus Types mRNA Measurement


name: Herpes Simplex Virus 1 and/or 2 Measurement


name: Herpes Simplex Virus 1 and/or 2 DNA Measurement


name: Dengue Virus 1, 2, 3, and/or 4 RNA Measurement


name: Human Rhinovirus and/or Enterovirus Nucleic Acid Measurement


name: Human Coronavirus NL63 and/or Human Coronavirus HKU1 RNA Measurement


name: Human Papillomavirus Type 11 DNA Measurement


name: Human Papillomavirus Type 16 DNA Measurement


name: Human Papillomavirus Type 18 DNA Measurement


name: Human Papillomavirus Type 31 DNA Measurement


name: Human Papillomavirus Type 33 DNA Measurement


name: Human Papillomavirus Type 35 DNA Measurement


name: Human Papillomavirus Type 45 DNA Measurement


name: Human Papillomavirus Type 51 DNA Measurement


name: Human Papillomavirus Type 52 DNA Measurement


name: Human Papillomavirus Type 53 DNA Measurement


name: Human Papillomavirus Type 56 DNA Measurement


name: Human Papillomavirus Type 57 DNA Measurement


name: Human Papillomavirus Type 58 DNA Measurement


name: Human Papillomavirus Type 59 DNA Measurement


name: Human Papillomavirus Type 6 DNA Measurement


name: Human Papillomavirus Type 66 DNA Measurement


name: Human Papillomavirus Type 67 DNA Measurement


name: Human Papillomavirus Type 68 DNA Measurement


name: Human T-Lymphotropic Virus RNA Measurement


name: Respiratory Syncytial Virus Type A RNA Measurement


name: Respiratory Syncytial Virus Type B RNA Measurement


name: Epstein Prostate Neuroendocrine Carcinoma Classification 2014


name: WHO Classification of Tumors of Hematopoietic And Lymphoid Tissue 2017


name: Heart Rate Variability, Average Standard Deviation NN Interval Measurement


name: Micronucleated Polychromatic Erythrocyte Count


name: Polychromatic Erythrocytes to Erythrocytes Ratio Measurement


name: Micronucleated Polychromatic Erythrocytes to Polychromatic Erythrocytes Ratio Measurement


name: Micronucleated Normochromatic Erythrocytes Count


name: Micronucleated Normochromatic Erythrocytes to Normochromatic Erythrocytes Ratio Measurement


name: Standard Deviation of the Mean of the Median Comet Tail Intensity


name: Standard Deviation of the Mean of the Median Comet Tail Moment


name: Hedgehog-Shaped Cells to Total Assessed Cells Ratio Measurement


name: SEND Genetic Toxicology Implementation Guide Version 1.0